Naresh K. Nayyar active positions
| Companies | Position | Start | End |
|---|---|---|---|
| TURG POIN | General Counsel | 31/05/2018 | - |
Career history of Naresh K. Nayyar
Former positions of Naresh K. Nayyar
| Companies | Position | Start | End |
|---|---|---|---|
| ATYR PHARMA, INC. | Corporate Officer/Principal | 31/03/2016 | 30/04/2018 |
Training of Naresh K. Nayyar
| University of Delhi | Doctorate Degree |
| University of Phoenix | Masters Business Admin |
Statistics
International
| United States | 4 |
| India | 2 |
Operational
| General Counsel | 1 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ATYR PHARMA, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by Jingrong Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Naresh K. Nayyar
- Experience
